Current advances in the development of therapies for neuromuscular disorders based on myostatin signalling, 3rd International Institute of Myology Workshop, Paris, September 12th, 2008.
Dumonceaux
Julie
J
Faculté de Médecine Pierre et Marie Curie, Université Paris VI, UPMC INSERM UMR S 974/CNRS UMR 7215 - Institut de Myologie, 105 bd de l'Hôpital, 75013 Paris, France.
Amthor
Helge
H
D000818:Animals; D002454:Cell Differentiation / Q000502:physiology; D015444:Exercise; D006801:Humans; D019042:Muscle Neoplasms / Q000378:metabolism; D055435:Myostatin / Q000037:antagonists & inhibitors / Q000378:metabolism*; D009468:Neuromuscular Diseases / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy; D018384:Oxidative Stress / Q000502:physiology; D012208:Rhabdomyosarcoma / Q000378:metabolism; D032496:Satellite Cells, Skeletal Muscle / Q000378:metabolism / Q000473:pathology; D015398:Signal Transduction / Q000502:physiology*
D055435:Myostatin